Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Antheia: The company raised $56 million of Series C venture funding in a deal led by EDBI and Global Health Investment Corporation on June 3, 2025. Echo Investment Capital, Sherpalo...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Neuralink: The company raised $650 million of Series E venture funding from G42, Lightspeed Commerce, and Valor Equity Partners on May 27, 2025, putting the company’s pre-money...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions CellCentric: The company raised $120 million of Series C venture funding in a deal led by RA Capital Management and Forbion on May 19, 2025. Avego Management and BrightEdge also...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $365 million of Series D venture funding from undisclosed investors on May 15, 2025, putting the company’s pre-money valuation at $1.24 billion. The...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $283 million of venture funding from undisclosed investors on May 1, 2025. The company is a developer of a drug discovery platform intended to reduce the...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
